Role of peroxisome proliferator-activated receptor gamma and its ligands in the treatment of hematological malignancies

31Citations
Citations of this article
46Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Peroxisome proliferator-activated receptor gamma (PPARγ) is a multifunctional transcription factor with important regulatory roles in inflammation, cellular growth, differentiation, and apoptosis. PPARγ is expressed in a variety of immune cells as well as in numerous leukemias and lymphomas. Here, we review recent studies that provide new insights into the mechanisms by which PPARγ ligands influence hematological malignant cell growth, differentiation, and survival. Understanding the diverse properties of PPARγ ligands is crucial for the development of new therapeutic approaches for hematological malignancies. Copyright © 2008 Tatiana M. Garcia-Bates et al.

Cite

CITATION STYLE

APA

Garcia-Bates, T. M., Lehmann, G. M., Simpson-Haidaris, P. J., Bernstein, S. H., Sime, P. J., & Phipps, R. P. (2008). Role of peroxisome proliferator-activated receptor gamma and its ligands in the treatment of hematological malignancies. PPAR Research. https://doi.org/10.1155/2008/834612

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free